Trinity Biotech Plc (TRIB)
7.00
+1.23
(+21.32%)
USD |
NASDAQ |
Oct 06, 16:00
6.00
-1.00
(-14.29%)
After-Hours: 20:00
Trinity Biotech Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2025 | 6.155M |
| September 30, 2025 | 1.337M |
| June 30, 2025 | 1.092M |
| March 31, 2025 | 3.815M |
| December 31, 2024 | 1.88M |
| September 30, 2024 | 6.438M |
| June 30, 2024 | 5.896M |
| March 31, 2024 | 20.85M |
| December 31, 2023 | -0.555M |
| September 30, 2023 | -0.572M |
| June 30, 2023 | -11.55M |
| March 31, 2023 | 4.254M |
| December 31, 2022 | -0.2306M |
| September 30, 2022 | -0.6883M |
| June 30, 2022 | |
| March 31, 2022 | |
| December 31, 2021 | -0.741M |
| September 30, 2021 | 0.987M |
| June 30, 2021 | -0.72M |
| March 31, 2021 | -0.701M |
| December 31, 2020 | 3.641M |
| September 30, 2020 | -0.79M |
| June 30, 2020 | -0.781M |
| March 31, 2020 | -0.79M |
| December 31, 2019 | 0.738M |
| Date | Value |
|---|---|
| September 30, 2019 | -0.758M |
| June 30, 2019 | -2.755M |
| March 31, 2019 | -0.758M |
| December 31, 2018 | 0.107M |
| September 30, 2018 | -12.04M |
| June 30, 2018 | 0.00 |
| March 31, 2018 | -0.434M |
| December 31, 2017 | 1.419M |
| September 30, 2017 | -1.793M |
| June 30, 2017 | -3.822M |
| March 31, 2017 | -3.847M |
| December 31, 2016 | 0.6892M |
| September 30, 2016 | -2.30M |
| June 30, 2016 | -5.811M |
| March 31, 2016 | -1.327M |
| December 31, 2015 | 6.364M |
| September 30, 2015 | 0.72M |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 3.605M |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | |
| December 31, 2013 | 3.588M |
| September 30, 2013 | -0.0119M |
Cash From Financing Definition
Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
| DBV Technologies SA | -0.1356M |
| Cellectis SA | -3.157M |
| Akari Therapeutics Plc | 8.034M |
| Autolus Therapeutics Plc | -2.144M |
| Evaxion AS | -- |
Cash from Financing (Quarterly) Related Metrics
| Free Cash Flow | -12.50M |
| Free Cash Flow Per Share (Quarterly) | -3.790 |
| Free Cash Flow to Equity (Quarterly) | -23.13M |
| Free Cash Flow to Firm (Quarterly) | 10.18M |
| Free Cash Flow Yield | -288.7% |